What patients think of automated whole-breast ultrasounds.
When it comes to breast ultrasound, the most important priority is efficacy. But, another paramount concern is patient comfort with the technology. And, with automated whole-breast ultrasound, there’s been little research to date regarding how women feel about undergoing this type of imaging.
Many studies have been published that highlight the effectiveness of automated whole-breast ultrasound in the screening detection of invasive breast cancers among women with dense breast tissue. A study published recently in The Breast Journal looked deeper and analyzed how women who had only previously undergone a mammogram responded to receiving an automated whole-breast ultrasound. The results were mainly positive.
The study
Researchers conducted a 28-question survey with 82 women receiving their baseline automated whole-breast ultrasound. Of that group, 82% reported the experience was positive, 2% indicated the experience was negative, and 15% remained neutral. After receiving an exam, more women were also aware that this type of imaging contained no ionizing radiation, increasing from 78.9% to 90.8%, respectively.
For many women, anxiety over breast screening can be a frequent concern, but worries among participating women dropped after the exam. Prior to the imaging, 47.5% of women indicated they had no anxiety, but that percentage increased to 64.6% after completion of the studies.
Related article: Automated Breast Ultrasound Use on the Rise
With mammography, another common complaint can be how long women have to stand still, compressed in a machine in order for the technologist to conduct the exam. Automated whole-breast ultrasound appeared to alleviate that concern: post-exam, more women revealed the length-of-time to complete the imaging was no longer a worry. Initially, 57.7% of patients reported having no concern about the time span, and that increased to 62.8%.
In a surprising result, however, women indicated their concerns about physical discomfort associated with automated whole-breast ultrasound actually increased after the exam. Initially, more than half-58.6% of women had no concerns about an automated whole-breast ultrasound being uncomfortable. But, after having one, that proportion dropped to 42.3%. Still, more patients reported little-to-no discomfort with an automated whole-breast ultrasound than they did with a mammogram, 81.7% to 61%, respectively.
Communication
Part of helping women become more comfortable with a new type of imaging exam is fostering communication with their healthcare provider. According to The Breast Journal study, women were widely varied on how they preferred to receive information about their breast health from their doctor. Many reported being comfortable with more than one mode of communication.
For example, 18% selected reading a printed pamphlet, 29% wanted a one-on-one conversation, 27% opted to glean information from websites, 22% leaned toward an email from their breast care center, 1% preferred social media, and 3% did not want information.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.